The shock factor: optimising antiplatelet therapy

28 August 2026 (10:20 - 10:29)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Associate Professor Jolanta Siller-Matula

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail

Opening address

Doctor P. Capranzano (Catania, IT)

Presentation thumbnail

The acute coronary syndrome challenge: speed as a priority in PCI

Professor D. Angiolillo (Jacksonville, US)

Presentation thumbnail

Tailoring IV antiplatelet therapy in chronic coronary syndromes

Associate Professor F. Pelliccia (Rome, IT)

Presentation thumbnail

Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock - discussion and Q&A

Access the full session

Session thumbnail

Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock

The Event

Event poster

ESC Congress 2026

28 August 2026 10:20 CET

You may be interested in

Congress Session

State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

14 March 2025

Congress Presentation

State-of-the-art lecture on contemporary management of cardiogenic shock in heart failure

29 August 2026

Congress Presentation

Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?

4 April 2025

Congress Presentation

Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital

21 March 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources